The Danish drugmaker is fighting on multiple fronts — and losing ground on most of them. While Novo Nordisk celebrates...
The numbers tell a stark story of transition. BioNTech’s Covid vaccine revenue is sliding toward a projected €2.0-2.3 billion for...
The gap between Siemens Healthineers’ strategic ambitions and its stock market performance has rarely been wider. While the medical technology...
Bayer shareholders have handed management a powerful financial weapon. At the company’s annual general meeting, they approved a blanket authorization...
The clock is ticking for BioNTech. After a 30-day rally that has pushed its stock up 23% to €92.70, the...
The telehealth operator Hims & Hers is navigating one of its most turbulent periods yet, caught between a costly strategic...
ImmunityBio has pulled off a remarkable feat in the Middle East, getting its immunotherapy ANKTIVA onto the Saudi Arabian market...
Ocugen is racing against its own balance sheet. The biotech has mapped out a clinical calendar for 2026 that packs...
Siemens Healthineers made a splash at Berlin’s DMEA healthcare conference this week, unveiling an ambitious artificial-intelligence strategy and a high-profile...
The contrast at Bayer has rarely been starker. At its Leverkusen headquarters, the company is celebrating a prestigious industry award...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com